Previous Article | Next Article ![]()
Journal of Virology, July 2000, p. 6300-6308, Vol. 74, No. 14
Pharmaceuticals & Biotechnology Laboratory,
Japan Energy Corporation, Toda-shi, Saitama,
335-8502,1 and Department of
Biomolecular Engineering, Graduate School of Engineering, Tohoku
University, Aoba-yama, Sendai 980-8579,2 Japan
Received 10 January 2000/Accepted 24 April 2000
A series of mouse monoclonal antibodies (MAbs) to the nonstructural
protein 3 (NS3) of hepatitis C virus was prepared. One of these MAbs,
designated 8D4, was found to inhibit NS3 protease activity. This
inhibition was competitive with respect to the substrate peptide
(Ki = 39 nM) but was significantly decreased by
the addition of the NS4A peptide, a coactivator of the NS3 protease.
8D4 also showed marked inhibition of the NS3-dependent cis processing of the NS3/4A polyprotein but had virtually
no effect on the succeeding NS3/4A-dependent trans
processing of the NS5A/5B polyprotein in vitro. Epitope mapping of 8D4
with a random peptide library revealed a consensus sequence, DxDLV, that matched residues 79 to 83 (DQDLV) of NS3, a region containing the
catalytic residue Asp-81. Furthermore, synthetic peptides including
this sequence were shown to block the ability of 8D4 to bind to NS3,
indicating that 8D4 interacts with the catalytic region of NS3. The
data showing decreased inhibition potency of 8D4 against the NS3/4A
complex suggest that 8D4 recognizes the conformational state of the
protease active site caused by the association of NS4A with the protease.
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Isolation and Characterization of Monoclonal
Antibodies That Inhibit Hepatitis C Virus NS3 Protease
*
Corresponding author. Present address: Division of
Viral Immunology, Center for AIDS Research, Kumamoto University, 2-2-1 Honjo, Kumamoto, 860-0811, Japan. Phone: 81-96-373-6530. Fax: 81-96-373-6532. E-mail:
uenot{at}kaiju.medic.kumamoto-u.ac.jp.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|